text: We investigated whether 5 to 20mg per week oral methotrexate could slow down disease progression in 44 patients with inclusion body myositis in a randomized double-blind placebo-controlled study over 48 weeks .
entities.text: methotrexate
entities.type: intervention
entities.text: disease progression
entities.type: outcome
entities.text: 44 patients with inclusion body myositis
entities.type: participant